8 months ago
ABBV
AnalystsSteve ChesneySteve Chesney's Stock Forecasts
AnalystsSteve Chesney
Sectors:
Analyst Ranking
Top 27%
#1126 out of 4172 analysts
Average Return
+2.55%
Win Rate
47%8 out of 17
Risk vs Reward
Poor
Good
Steve Chesney's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Idexx Laboratories IncIDXX | +31.24% | $372.64 | $489.05 | 2022-11-01 - 2023-03-27 | Strong Buy |
Idexx Laboratories IncIDXX | +20.20% | $406.87 | $489.05 | 2022-08-02 - 2023-03-27 | Strong Buy |
Merck & Co IncMRK | +17.44% | $91.05 | $106.93 | 2022-10-10 - 2023-03-27 | Strong Buy |
Abbvie IncABBV | +17.15% | $97.31 | $114.00 | 2020-06-22 - 2021-06-23 | Strong Buy |
Merck & Co IncMRK | +14.03% | $93.77 | $106.93 | 2022-07-12 - 2023-03-27 | Strong Buy |
Steve Chesney Analyst Color
Get additional color on Steve Chesney's coverage of popular stocks
Steve Chesney's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Merck & Co IncMRK | 4 | Strong Buy | $127.00 | +18.77% | Maintains | 21 days ago |
Abbvie IncABBV | 4 | Hold | $154.00 | -2.25% | Maintains | 2 months ago |
Idexx Laboratories IncIDXX | 3 | Strong Buy | $600.00 | +22.69% | Maintains | 2 months ago |
Bristol Myers Squibb CoBMY | 5 | Strong Buy | $90.00 | +32.22% | Maintains | 2 months ago |
Pfizer IncPFE | 2 | Hold | $46.00 | +14.37% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 4 | Hold | $168.00 | +9.59% | Maintains | 2 months ago |
Biogen IncBIIB | 3 | Hold | $295.00 | +9.27% | Maintains | 4 months ago |
Amgen IncAMGN | 2 | Strong Sell | $182.00 | -23.13% | Maintains | 8 months ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.